How much is Ambros Therapeutics worth in 2026?

Ambros Therapeutics has a current valuation of N/A based on their Early Stage VC (Series A) round and secondary market data.

How much funding has Ambros Therapeutics raised?

Ambros Therapeutics has raised N/A in total funding across 1 funding rounds.

Ambros Therapeutics

Biotechnology

Ambros Therapeutics valuation and funding history | Last updated: December 16, 2025 | 1 funding rounds

Current Valuation

N/A

As of December 16, 2025

Total Funding Raised

N/A

Across 1 round

Last Round

Early Stage VC (Series A)

$154.0M

Last Funding

Dec 2025

Funding date

Capital Efficiency

N/A

Valuation / Funding

Funding History & Valuation Timeline

Complete history of all funding rounds and valuation milestones

Date	Round	Amount	Post-Valuation	Growth
December 16, 2025	Early Stage VC (Series A)	$154.0M	N/A	-

Valuation Analysis

Current Valuation Metrics

Ambros Therapeutics is currently valued at N/A as of December 16, 2025.

Track Ambros Therapeutics Valuation Updates

Get notified when Ambros Therapeutics raises new funding or valuation changes

Explore More Data

Detailed analysis for Ambros Therapeutics

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

View 5 companies free

Create a free account to unlock Ambros Therapeutics's valuation history, funding rounds, and growth metrics.

No credit card required

What is Ambros Therapeutics Worth in 2026?

Ambros Therapeutics is a leading private company in the Biotechnology sector. Track Ambros Therapeutics's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.

How Ambros Therapeutics Valuation is Determined

Private company valuations like Ambros Therapeutics's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.